Arkolith/Insider Trading/TCRT/Form 4

Hofmeister Robert

DirectorAlaunos Therapeutics, Inc. (TCRT) · full profile →Form 4 · filed Apr 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2023Grant(A)150K—$0150K
Mar 30, 2023Grant(A)17K—$017K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-011453) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML